Breast cancer prognostic classification in the molecular era: the role of histological grade.
about
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomesGenomic approaches in breast cancer researchPlasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision MedicineStatistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practiceNew breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology imagesRespective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinomaBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Computer-aided assessment of tumor grade for breast cancer in ultrasound images.The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases.A data similarity-based strategy for meta-analysis of transcriptional profiles in cancer.Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example.Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinomaIntegration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Expression of Krüppel-like factor 4 in breast cancer tissues and its effects on the proliferation of breast cancer MDA-MB-231 cells.GD2 expression in breast cancer.An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancerComputational prognostic indicators for breast cancer.Clinicopathologic subtypes and compromise of lymph nodes in patients with breast cancer.Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis.Classification of patients with breast cancer according to Nottingham prognostic index highlights significant differences in immunohistochemical marker expression.Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data.A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling.Diallyl disulfide suppresses SRC/Ras/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a.Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG studyStromal expression of miR-21 identifies high-risk group in triple-negative breast cancer.The molecular pathology of breast cancer progression.Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreementThe potential of hypoxia markers as target for breast molecular imaging--a systematic review and meta-analysis of human marker expression.Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.Insight into the heterogeneity of breast cancer through next-generation sequencing.Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive valueMicroarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.Rare variants in the ATM gene and risk of breast cancerNovel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.A ranking-based meta-analysis reveals let-7 family as a meta-signature for grade classification in breast cancer
P2860
Q21195193-60726F2B-1A46-4E2C-B65C-D4E3A1C3DA05Q26865893-DF9B2506-FDF0-4FB0-97A5-D009221B49A2Q28067626-A208FF3E-C785-4B29-BB4B-A45101035085Q28078729-783725AE-490C-4D0B-B65E-6383FB8FBB1EQ28646873-13C00D61-4A91-4FDC-B9AF-5249610F23D6Q28730529-750947CB-3E2C-4DD9-BF74-08C4F0B9020FQ30245184-15F7ABA4-D077-4611-897E-09AB968B2ACBQ30416061-DE1A24DA-2659-495B-9781-1F485D67E37CQ30446768-60D9CCFC-EF68-4A2D-9734-50D1D6C6A57EQ30587056-6792DA3F-193B-4F61-B6B6-716A719A0657Q31043651-1144A00D-2A87-45B7-AD73-070476F9E277Q31052319-80FB8FF3-D690-4865-9F4E-8E7C65F8E7DAQ33555247-74C90D39-5574-4F6A-87CB-42FFD11A814CQ33670486-85B8FF0C-94A5-4F39-99C5-D8E357E5999CQ33723841-25653BE4-048C-4726-B0F9-28DB9A461142Q33761830-4C815A6C-8929-41A9-81B9-F00675BBFFABQ33892460-60DCC8FA-1097-4B87-A2BA-F531BDF5CA60Q33921791-8F7B2157-FDA9-43D8-9386-312BB9BC735CQ33988310-1C09C6F9-BB87-45AC-81E0-4CF33EEBFF17Q33994291-0D306282-01E7-430E-96B2-7C78CC977DACQ34042565-13D643AA-C81C-4F48-AC5A-EA6EC9FDC28CQ34190743-14BB00BB-043F-4D17-B351-ADB317FFEB89Q34198351-CE68E0DD-80B5-48B1-98FA-F8960BF9709AQ34206647-72773B99-B78C-4122-B1DE-E2D34FB09B22Q34277400-25AB5F24-7245-48E4-A5A2-BEE53E65E744Q34334455-D7F51258-D3A8-4879-A3D0-A6AE2C4F9F5FQ34514418-51F1604F-FC80-4B95-BD13-F5F114B923DAQ34559124-074E7B4C-1B53-44E1-A171-C6DF14A56DD9Q34647811-1FBA9B17-38B7-42AE-AABB-071E4588AF8DQ34752938-2919DC69-2B37-419C-9CE1-89BE54AB4A18Q34820314-99DB73C6-7AA5-4DE0-AE75-DCF34C2E06D8Q35037251-CDECCA73-D8FA-497F-A620-48A774361709Q35086250-1EF88390-5739-4AC4-BFD8-453990AAF8FAQ35125648-E9D42A3F-38D7-4F8C-8376-6BDC20B6B603Q35370090-198E00B9-6607-4574-8DCB-411AF8AAE05CQ35503492-D5A013A3-4A95-4296-BA5F-46746993EBF7Q35558070-F4630595-7B0F-4D08-8312-A09C72CD6167Q35608690-B9F367A9-1E8F-43FF-8A31-0B2C421C8CF0Q35609695-88DC40D6-FB75-4CB2-AE5F-C6848B8D6027Q35610804-FB7E4CC1-4767-4D02-A857-7A497E7044F9
P2860
Breast cancer prognostic classification in the molecular era: the role of histological grade.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Breast cancer prognostic class ...... he role of histological grade.
@ast
Breast cancer prognostic class ...... he role of histological grade.
@en
Breast cancer prognostic class ...... he role of histological grade.
@nl
type
label
Breast cancer prognostic class ...... he role of histological grade.
@ast
Breast cancer prognostic class ...... he role of histological grade.
@en
Breast cancer prognostic class ...... he role of histological grade.
@nl
prefLabel
Breast cancer prognostic class ...... he role of histological grade.
@ast
Breast cancer prognostic class ...... he role of histological grade.
@en
Breast cancer prognostic class ...... he role of histological grade.
@nl
P2093
P2860
P50
P921
P356
P1476
Breast cancer prognostic class ...... he role of histological grade.
@en
P2093
Andrea L Richardson
David J Dabbs
Frederick Baehner
Gary M Tse
José Palacios
Puay-Hoon Tan
Shu Ichihara
Stuart J Schnitt
Sunil Badve
Thomas Decker
P2860
P2888
P356
10.1186/BCR2607
P50
P577
2010-07-30T00:00:00Z
P5875
P6179
1009736506